Journal article
Renal Function, Peak Anti‐Xa Levels and Enoxaparin Dosing
Abstract
Background: Low molecular weight heparin is administered in a fixed, weight‐adjusted dose without laboratory monitoring in the majority of patients. However, there is still uncertainty regarding optimum dosing in patients with renal impairment. Aim: To examine the association between peak anti‐Xa levels and creatinine clearance in patients treated with enoxaparin. Method: Prospective study of hospitalised patients receiving enoxaparin 1 …
Authors
Peng YG; Eikelboom JW; Tenni P; McQuillan A; Thorn J
Journal
Journal of Pharmacy Practice and Research, Vol. 34, No. 1, pp. 14–17
Publisher
Wiley
Publication Date
3 2004
DOI
10.1002/jppr200434114
ISSN
1445-937X